Proton Therapy Center
Proton Therapy Center Czech s.r.o. operates a single-specialty proton radiotherapy facility in Prague using Pencil Beam Scanning (PBS) technology across four irradiation rooms, serving oncology patients from the Czech Republic and 59 other countries with full coverage by Czech health insurance.
- Company typePrivate
- Founded2012
- HeadquartersPrague, Czechia
- Headcount51–100
- GTM typeB2C
- OfferingServices
What Proton Therapy Center does
Proton Therapy Center Czech s.r.o. (PTC) operates a single-specialty proton radiotherapy facility in Prague, Czech Republic, on the campus of Fakultní nemocnice Bulovka. Founded in 2012 and structured as a privately held Czech s.r.o. (IČ: 26466791), the center operates four irradiation rooms equipped with Pencil Beam Scanning (PBS) technology, which delivers proton dose layer by layer using the Bragg Peak physical property to maximize tumor dose and minimize exposure to surrounding healthy tissue. Since opening, PTC has treated approximately 16,000 oncology patients from 60 countries across prostate, breast, head and neck, central nervous system, lymphoma, pediatric, gastrointestinal, and lung cancers, and self-reports being among the top five proton therapy centers globally based on long-term outcomes.
The business model is anchored on reimbursement from Czech public health insurers, with secondary revenue from Slovak insurer VŠZP, foreign insurers, self-pay patients, and externally referred diagnostic imaging (MRI, PET-CT). Treatment is fully covered by Czech health insurance, with the center handling approval paperwork on patients' behalf. A free initial consultation (~30–40 minutes) functions as the top-of-funnel acquisition mechanism, supported by a 24-hour booking SLA, dedicated personal patient coordinators, multilingual support, and an integrated ecosystem including on-site chemotherapy for breast cancer, a charitable foundation providing accommodation via Hotel Pawlownia, E-Ambulance video consultations, and dedicated disease portals (Centrum karcinomu prostaty and Centrum karcinomu prsu). The center recently extended into MRI-based prostate cancer screening as part of a national pilot, and co-organized a Particle Therapy Masterclass with Charles University's Faculty of Mathematics and Physics in March 2024.
Proton Therapy Center firmographics
Firmographics- Name
- Proton Therapy Center
- Legal name
- Proton Therapy Center Czech s.r.o.
- Website
- https://ptc.cz
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Proton Therapy Center Czech s.r.o. operates a single-specialty proton radiotherapy facility in Prague using Pencil Beam Scanning (PBS) technology across four irradiation rooms, serving oncology patients from the Czech Republic and 59 other countries with full coverage by Czech health insurance.
- Ownership category
- akta.pro rank
Proton Therapy Center industry classification
Industry- Product category
- Radiation Oncology / Proton Therapy Services
- NAICS
- Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Diagnostic Imaging Centers (621512)
- SIC
- Services-General Medical & Surgical Hospitals, Nec (8062), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Radiation Oncology (HLAKAFAC)
- akta.pro secondary industry
- Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology) (HLAFAKAB)
Keywords
Where Proton Therapy Center is headquartered
LocationHeadquarters
- HQ city
- Prague
- HQ country
- Czechia
- HQ region
- Europe
Offices1 record
Markets served
Proton Therapy Center business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Infrastructure, Technology or R&D, Operations, Marketing or Sales
Revenue model
- Health Insurance Reimbursement: The primary revenue stream is reimbursement from health insurance companies. Proton Therapy Center has contracts with Czech health insurance companies (e.g., Všeobecná zdravotní pojišťovna, VŠZP) as well as Slovak and foreign insurance companies. Treatment is fully covered by health insurance. The center handles insurance approval paperwork for patients.
- Self-Paying Patients: Patients can choose to pay for proton treatment out-of-pocket without insurance involvement. Pricing is individualized based on the number of radiation doses determined by the doctor based on diagnosis and disease extent. The center emphasizes that this option is not actively promoted as they prefer working with insurance.
- Diagnostic Services: The center offers diagnostic imaging services (MRI, PET/CT) not only to its own patients but also to external patients with a doctor's referral, generating additional revenue.
- Chemotherapy Services: The center newly provides chemotherapy services for breast cancer patients directly at the proton center, offering integrated cancer care.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | Standard treatment course — covered by health insurance |
| Freemium | Pay-as-you-go | Initial consultation — free |
| Unit Pricing | Pay-as-you-go | Self-pay treatment — individualized pricing |
| Unit Pricing | Multi-year contract | Parking permit — 300 CZK per 30 days |
Go-to-market motion1 record
Distribution channels5 records
Marketing channels7 records
Proton Therapy Center product offering
Product offeringCore offering
Proton Therapy Center provides proton radiotherapy cancer treatment using Pencil Beam Scanning (PBS) technology in 4 irradiation rooms in Prague. The center treats tumors of the prostate, breast, head and neck, central nervous system, lymphomas, pediatric cancers, gastrointestinal tract, and lungs, with proton beam precision minimizing damage to surrounding healthy tissue. Treatment is fully covered by Czech, Slovak, and other contracted health insurance companies, with additional services including chemotherapy, MRI, and PET/CT diagnostics.
Product overview
Proton Therapy Center operates as a single-specialty oncology hospital offering proton radiotherapy as its primary service, alongside supporting diagnostic and therapeutic offerings. The core product is proton radiotherapy (Pencil Beam Scanning, PBS) for cancer treatment. The portfolio includes dedicated sub-brands for specific cancer types: Centrum karcinomu prsu (Breast Cancer Center) and Centrum karcinomu prostaty (Prostate Cancer Center), both web portals offering information and care navigation. Supporting services include chemotherapy administration, modern diagnostics (MRI, PET/CT), a Nadační fond (charitable foundation) providing patient support (accommodation, transport, financial aid), and E-Ambulance (video consultation with physicians). The center treats conditions including prostate, breast, head and neck, CNS, lymphomas, pediatric tumors, gastrointestinal tract, and lung cancers. All treatment is fully covered by Czech health insurance.
Differentiator
Problem solved
Functional benefit
Brands
- Centrum karcinomu prostaty: Prostate Cancer Center - specialized information portal for prostate cancer patients
- Centrum karcinomu prsu
- Centrum moderní diagnostiky
- Protonoví bojovníci
- E-Ambulance
- Nadační fond pro protonovou terapii
Products and services
- Proton Radiotherapy (Pencil Beam Scanning / PBS) Precise, minimally invasive cancer treatment that uses a proton beam to deposit radiation dose directly into tumors via Pencil Beam Scanning technology, minimizing damage to surrounding healthy tissues. The center operates 4 irradiation rooms and has treated approximately 16,000 patients from 60 countries since 2012.
- Chemotherapy Chemotherapy administration for breast cancer patients, provided directly on-site at the Proton Therapy Center, enabling patients to receive combined chemotherapy and radiotherapy treatment in a single facility.
- Modern Diagnostics (MRI / PET/CT) Advanced diagnostic imaging services including MRI (magnetic resonance imaging) and PET/CT examinations, available both to Proton Therapy Center patients and to external patients with a valid physician referral.
Quantifiable outcome
- 96.5-98% cure rate for low-risk prostate cancer patients
- +6 more outcomes
Companies that use Proton Therapy Center
Customer profileNamed customers12 records
Segments9 records
Ideal customer profiles4 records
Proton Therapy Center technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Proton Therapy Center partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core, major and minor.
- Hotel PawlowniacoreSince September 2022, the Nadační fond (Foundation) has partnered with Hotel Pawlownia, located within walking distance of Proton Therapy Center. The hotel is reserved exclusively for PTC patients during their treatment period, offered at cost price. This partnership addresses the accommodation needs of non-Prague patients who need to stay in Prague for extended treatment periods (weeks to months).
- Všeobecná zdravotní pojišťovna (VŠZP)coreSuccessful cooperation with Slovak public health insurer VŠZP. Proton treatment has been approved for more than 300 Slovak insured persons. The center assists Slovak patients with insurance approval processes and international treatment authorization.
- Fakultní nemocnice Motol (Motol University Hospital)majorPartner in the Breast Cancer Center (Centrum karcinomu prsu) project launched in March 2022. The center provides comprehensive breast cancer information and care coordination, with Motol providing specialized medical expertise and referral pathways for integrated patient care.
- Všeobecná fakultní nemocnice (VFN — General University Hospital)majorPartner in the Breast Cancer Center project. VFN provides specialized medical expertise and participates in the network of care for breast cancer patients coordinated through the center.
- Nemocnice Na Františku (Na Františku Hospital)majorPartner in the Breast Cancer Center project, specializing in breast reconstruction surgery after cancer treatment. Also partners on breast cancer care pathways.
- Ústřední vojenská nemocnice Praha (Central Military Hospital Prague)majorPartner in the Breast Cancer Center project, providing military and specialized healthcare services within the breast cancer care network.
- Mamodiagnostické centrum WaltrovkaminorPartner in the Breast Cancer Center project, providing mammodiagnostics services within the breast cancer care network.
- Nemocnice Hořovice (Hořovice Hospital)minorPartner in the Breast Cancer Center project, providing oncology care within the breast cancer patient care network.
- Matematicko-fyzikální fakulta UK (MFF UK — Faculty of Mathematics and Physics, Charles University)minorIn March 2024, the center co-organized a Particle Therapy Masterclass with MFF UK, including an excursion for participants. This educational partnership supports training and awareness about proton/particle therapy.
Scale indicators10 records
Recent moves10 records
Expansion highlights6 records
Proton Therapy Center competitors and assessment
Company assessmentDirect peers
- Trento Proton Therapy Center (APSS Trento): The Trento Proton Therapy Center is an Italian public proton therapy facility operated by the provincial health authority. Like PTC, it is a publicly reimbursed, single-site proton center treating cancers of the prostate, breast, head and neck, and other indications under Italy's national health service.
- Heidelberg Ion-Beam Therapy Center (HIT): HIT at Heidelberg University Hospital operates proton and carbon-ion therapy in a single-site academic setting. It is comparable to PTC in offering PBS-style precision particle therapy across multiple indications and serves as a major European referral center for complex cases.
- Centre de Protonthérapie d'Orsay (Institut Curie): The Institut Curie's proton therapy center in Orsay is one of Europe's longest-established single-site proton facilities. It treats a similar mix of pediatric, ocular, head-and-neck, and pelvic tumors under public reimbursement, and shares PTC's profile as a high-volume standalone proton center in a public-payer system.
- University College London Hospitals Proton Therapy Centre: UCLH's proton center is a UK NHS single-site proton therapy facility treating pediatric and adult cancers. Comparable to PTC in operating model, indication mix, and reliance on a national public payer (NHS England).
- Westdeutsches Protonentherapiezentrum Essen (WPE): WPE at University Hospital Essen is one of Germany's major academic proton therapy centers. It operates a similar single-site PBS-based proton facility under the German public reimbursement system, treating comparable indications and competing for European proton patients.
- MedAustron: MedAustron in Wiener Neustadt, Austria is a European ion beam therapy center offering both proton and carbon-ion therapy. It is one of the closest geographic and structural peers to PTC — a single-site regional particle therapy facility serving an international patient base with insurance reimbursement contracts.
- The Christie Proton Therapy Centre: Part of The Christie NHS Foundation Trust in Manchester, this is a leading UK NHS proton therapy center treating pediatric and adult cancers. It shares PTC's NHS-style reimbursement model, multi-indication proton offering, and role as a referral hub within a national cancer network.
- Rinecker Proton Therapy Center (RPTC): RPTC in Munich is one of Germany's first and largest standalone proton therapy centers, treating both private and publicly insured patients across multiple indications. It competes directly with PTC for cross-border European proton patients and operates a similar multi-room single-site model.
- Paul Scherrer Institute (PSI) — Center for Proton Therapy: PSI in Villigen, Switzerland operates one of the world's most experienced proton therapy facilities, treating ocular tumors and other indications with deep outcomes data. It is a comparable single-site proton center serving a mix of domestic insured and international patients.
Broad incumbents
- Ion Beam Applications (IBA): IBA is the world's leading manufacturer of proton therapy systems and a supplier of equipment to many of the centers comparable to PTC. While IBA does not operate treatment centers itself, it is the closest broad incumbent shaping the proton therapy ecosystem in which PTC competes.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Proton Therapy Center social profiles
Digital presenceProton Therapy Center compliance and trust
Trust signalCompliance1 record
Proton Therapy Center financial estimates
Financial estimateRevenue estimate
Valuation estimate
Proton Therapy Center leadership team
Management profileNumber of profiles
Profiles3 records
Proton Therapy Center funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Proton Therapy Center M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Proton Therapy Center
What does Proton Therapy Center do?
Proton Therapy Center provides proton radiotherapy cancer treatment using Pencil Beam Scanning (PBS) technology in 4 irradiation rooms in Prague. The center treats tumors of the prostate, breast, head and neck, central nervous system, lymphomas, pediatric cancers, gastrointestinal tract, and lungs, with proton beam precision minimizing damage to surrounding healthy tissue. Treatment is fully covered by Czech, Slovak, and other contracted health insurance companies, with additional services including chemotherapy, MRI, and PET/CT diagnostics.
Is Proton Therapy Center a public or private company?
Proton Therapy Center is a private company. It is classified as unknown and is currently operating.
When was Proton Therapy Center founded?
Proton Therapy Center was founded in 2012. It employs 51 to 100 people.
Where is Proton Therapy Center based?
Proton Therapy Center is headquartered in Prague, Czechia, in the Europe region.
How does Proton Therapy Center make money?
Four revenue lines are on record. Health Insurance Reimbursement is the primary driver. The others are self-Paying Patients, diagnostic Services and chemotherapy Services.
Who are Proton Therapy Center's main competitors?
Direct peers on record are Trento Proton Therapy Center (APSS Trento), Heidelberg Ion-Beam Therapy Center (HIT), Centre de Protonthérapie d'Orsay (Institut Curie), University College London Hospitals Proton Therapy Centre, Westdeutsches Protonentherapiezentrum Essen (WPE), MedAustron, The Christie Proton Therapy Centre, Rinecker Proton Therapy Center (RPTC) and Paul Scherrer Institute (PSI) — Center for Proton Therapy. Ion Beam Applications (IBA) is listed as a broad incumbent.
Does Proton Therapy Center have an API?
No public API is recorded for Proton Therapy Center.
What industry is Proton Therapy Center in?
Proton Therapy Center's product category is Radiation Oncology / Proton Therapy Services. Its primary akta.pro industry code is HLAKAFAC, Radiation Oncology, with a secondary code of HLAFAKAB, Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology). Its NAICS code is 622310 and its SIC code is 8062.